|
|
|
Volumn 29, Issue 9, 2002, Pages 1675-1687
|
|
A new LH-RH agonist for treatment of prostate cancer, 3-month controlled-release formulation of goserelin acetate (Zoladex LA 10.8 mg depot)--outline of pre-clinical and clinical studies
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
GONADORELIN;
GOSERELIN;
ANIMAL;
CHEMISTRY;
DELAYED RELEASE FORMULATION;
DRUG POTENTIATION;
HUMAN;
MALE;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PROSTATE TUMOR;
RETROSPECTIVE STUDY;
REVIEW;
ANIMALS;
ANTINEOPLASTIC AGENTS, HORMONAL;
CLINICAL TRIALS, PHASE II;
CLINICAL TRIALS, PHASE III;
DELAYED-ACTION PREPARATIONS;
GONADOTROPIN-RELEASING HORMONE;
GOSERELIN;
HUMANS;
MALE;
PROSTATIC NEOPLASMS;
RETROSPECTIVE STUDIES;
|
|
EID: 0036731439
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (8)
|
|
References (17)
|
